LGM

Logos Global Management Portfolio holdings

AUM $749M
This Quarter Return
-5.77%
1 Year Return
+18.94%
3 Year Return
+431.72%
5 Year Return
+481.1%
10 Year Return
–
AUM
$1.17B
AUM Growth
+$1.17B
Cap. Flow
+$299M
Cap. Flow %
25.68%
Top 10 Hldgs %
51.12%
Holding
71
New
18
Increased
15
Reduced
14
Closed
14

Top Buys

1
VERV
Verve Therapeutics
VERV
$45.7M
2
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$38M
3
LENZ
LENZ Therapeutics
LENZ
$32.9M
4
IOVA icon
Iovance Biotherapeutics
IOVA
$29.3M
5
IPSC icon
Century Therapeutics
IPSC
$29M

Top Sells

1
DYN icon
Dyne Therapeutics
DYN
$24.2M
2
RPTX icon
Repare Therapeutics
RPTX
$17.8M
3
BTAI icon
BioXcel Therapeutics
BTAI
$17.3M
4
KYMR icon
Kymera Therapeutics
KYMR
$10.1M
5
VINC
Vincerx Pharma, Inc. Common Stock
VINC
$9.26M

Sector Composition

1 Healthcare 99.71%
2 Financials 0.27%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PRDS
51
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$1.23M 0.1%
123,543
-176,457
-59% -$1.76M
OBIO icon
52
Orchestra BioMed
OBIO
$147M
$1.02M 0.09%
100,000
-200,000
-67% -$2.04M
RACB
53
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$1.01M 0.09%
100,000
-200,000
-67% -$2.03M
DAWN icon
54
Day One Biopharmaceuticals
DAWN
$769M
$844K 0.07%
+37,069
New +$844K
MLTX icon
55
MoonLake Immunotherapeutics
MLTX
$3.54B
$518K 0.04%
50,000
-150,000
-75% -$1.55M
NUVB.WS icon
56
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$68M
$173K 0.01%
66,666
– –
MREO
57
Mereo BioPharma
MREO
$272M
$149K 0.01%
+46,984
New +$149K
BOLT icon
58
Bolt Biotherapeutics
BOLT
$9.85M
– –
-150,000
Closed -$4.94M
CNTB
59
Connect Biopharma
CNTB
$115M
– –
-150,000
Closed -$2.78M
HRMY icon
60
Harmony Biosciences
HRMY
$2.12B
– –
-100,000
Closed -$3.3M
KYMR icon
61
Kymera Therapeutics
KYMR
$2.95B
– –
-260,920
Closed -$10.1M
LRMR icon
62
Larimar Therapeutics
LRMR
$310M
– –
-230,000
Closed -$3.36M
SPRY icon
63
ARS Pharmaceuticals
SPRY
$1.15B
– –
-125,000
Closed -$5.45M
VRDN icon
64
Viridian Therapeutics
VRDN
$1.5B
– –
-550,000
Closed -$9.19M
VIRX
65
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
– –
-470,000
Closed -$4.35M
VINC
66
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
– –
-480,000
Closed -$9.26M
PNT
67
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
– –
-500,000
Closed -$5.26M
LHDX
68
DELISTED
Lucira Health, Inc. Common Stock
LHDX
– –
-250,000
Closed -$3.03M
EAR
69
DELISTED
Eargo, Inc. Common Stock
EAR
– –
-50,000
Closed -$2.5M
CEREW
70
DELISTED
Cerevel Therapeutics Holdings, Inc. Warrant
CEREW
– –
-33,333
Closed -$144K
BTAI icon
71
BioXcel Therapeutics
BTAI
$59M
– –
-400,000
Closed -$17.3M
1 2
3